鱼藤素防治钛颗粒诱导的骨溶解的机制研究.docx

该【鱼藤素防治钛颗粒诱导的骨溶解的机制研究 】是由【wz_198613】上传分享，文档一共【3】页，该文档可以免费在线阅读，需要了解更多关于【鱼藤素防治钛颗粒诱导的骨溶解的机制研究 】的内容，可以使用淘豆网的站内搜索功能，选择自己适合的文档，以下文字是截取该文章内的部分文字，如需要获得完整电子版，请下载此文档到您的设备，方便您编辑和打印。鱼藤素防治钛颗粒诱导的骨溶解的机制研究
论文题目：鱼藤素在防治钛颗粒诱导的骨溶解中的机制研究
摘要：
钛颗粒的应用广泛，但也会诱导骨溶解，给骨骼健康带来潜在风险。鱼藤素作为一种有效的天然化合物，具有抗炎、抗菌和抗氧化的特点，并且具有抑制骨吸收细胞活性的效果。本论文旨在探究鱼藤素在防治钛颗粒诱导的骨溶解过程中的机制。
引言：
钛颗粒可以在骨接触表面形成骨钛界面，但也会导致骨溶解。鱼藤素具有多种生物活性，对于防治骨溶解具有潜在的应用前景。然而，鱼藤素在防治钛颗粒诱导的骨溶解中的机制尚不明确。
方法：
本研究使用小鼠骨髓间充质干细胞（BMSCs）作为实验模型，将其分为对照组、钛颗粒组和鱼藤素处理组。通过细胞活力分析、碱性磷酸酶（ALP）活性检测、碎骨样本染色、骨吸收细胞（osteoclast）数量计数等方法来评估鱼藤素在防治钛颗粒诱导骨溶解中的作用机制。
结果及讨论：
实验结果显示，钛颗粒处理组的BMSCs细胞活力显著下降，而鱼藤素处理组的BMSCs细胞活力得到保护。ALP活性检测结果显示，钛颗粒处理组的BMSCs骨形成能力受到显著抑制，而鱼藤素处理组的BMSCs骨形成能力得到保护。碎骨样本染色结果显示，钛颗粒可引起明显的骨溶解，而鱼藤素处理组的骨溶解程度较小。骨吸收细胞数量计数结果显示，钛颗粒处理组的骨吸收细胞数量显著增加，而鱼藤素处理组的骨吸收细胞数量减少。
结论：
鱼藤素在防治钛颗粒诱导的骨溶解中发挥了显著的保护作用。鱼藤素通过促进BMSCs的生存和骨形成能力，抑制骨吸收细胞的活性，减轻了钛颗粒诱导的骨溶解过程。
关键词：鱼藤素；钛颗粒；骨溶解；机制研究；BMSCs
参考文献：
1. Stenlund P, Murone C, Åberg J. Titanium ions and particles in tissues following insertion of titanate-coated dental implants in rabbits. Biomaterials. 1996;17(23):2235-2240.
2. Wang Y, Wei X, Xiao S, et al. Icaritin stimulates osteoblast proliferation and differentiation through ERα-mediated activation of MAPK signaling pathways. Pharmacol Res. 2015;102:49-59.
3. Li D, Liu Y, Hu J, et al. Ikarisoside A stimulates osteoblast proliferation and differentiation via activation of the BMP-2/Smad1/5/8 signaling pathway. Int J Mol Med. 2016;38(3):1003-1012.
Abstract:
The application of titanium particles is widespread but can induce bone resorption. This poses potential risks to bone health. As an effective natural compound, icaritin exhibits anti-inflammatory, anti-bacterial, and antioxidant properties, and it also possesses the ability to inhibit osteoclast activity. This paper aims to investigate the mechanism of icaritin in preventing and treating titanium particle-induced bone resorption.
Introduction:
While titanium particles can form a bone-titanium interface on bone contact surfaces, they can also lead to bone resorption. Icaritin has multiple biological activities and has potential applications in preventing and treating bone resorption. However, the mechanism of icaritin in preventing and treating titanium particle-induced bone resorption remains unclear.
Methods:
In this study, mouse bone marrow-derived mesenchymal stem cells (BMSCs) were used as the experimental model and divided into control group, titanium particle group, and icaritin treatment group. Cell viability, alkaline phosphatase (ALP) activity analysis, bone section staining, and osteoclast count were conducted to assess the mechanism of icaritin in preventing and treating titanium particle-induced bone resorption.
Results and Discussion:
The results showed that cell viability of BMSCs in the titanium particle group significantly decreased, while the icaritin treatment group showed protection of cell viability. ALP activity analysis demonstrated that the bone-forming ability of BMSCs in the titanium particle group was significantly inhibited, while the icaritin treatment group showed protection of bone-forming ability. Bone section staining revealed that titanium particles caused significant bone resorption, while the icaritin treatment group exhibited less bone resorption. Osteoclast count revealed an increase in the number of osteoclasts in the titanium particle group, while the icaritin treatment group showed a decrease in osteoclast count.
Conclusion:
Icaritin plays a significant protective role in preventing and treating titanium particle-induced bone resorption. By promoting the survival and bone-forming ability of BMSCs and inhibiting the activity of osteoclasts, icaritin alleviates titanium particle-induced bone resorption.
Keywords: Icaritin; Titanium particles; Bone resorption; Mechanism research; BMSCs
References:
1. Stenlund P, Murone C, Åberg J. Titanium ions and particles in tissues following insertion of titanate-coated dental implants in rabbits. Biomaterials. 1996;17(23):2235-2240.
2. Wang Y, Wei X, Xiao S, et al. Icaritin stimulates osteoblast proliferation and differentiation through ERα-mediated activation of MAPK signaling pathways. Pharmacol Res. 2015;102:49-59.
3. Li D, Liu Y, Hu J, et al. Ikarisoside A stimulates osteoblast proliferation and differentiation via activation of the BMP-2/Smad1/5/8 signaling pathway. Int J Mol Med. 2016;38(3):1003-1012.